Search Results - "KISHAN, J"

Adaptation to Stressors by Systemic Protein Amyloidogenesis by Audas, Timothy E., Audas, Danielle E., Jacob, Mathieu D., Ho, J.J. David, Khacho, Mireille, Wang, Miling, Perera, J. Kishan, Gardiner, Caroline, Bennett, Clay A., Head, Trajen, Kryvenko, Oleksandr N., Jorda, Mercé, Daunert, Sylvia, Malhotra, Arun, Trinkle-Mulcahy, Laura, Gonzalgo, Mark L., Lee, Stephen

“…The amyloid state of protein organization is typically associated with debilitating human neuropathies and is seldom observed in physiology. Here, we uncover a…”
Get full text

Cancer Cells Exploit eIF4E2-Directed Synthesis of Hypoxia Response Proteins to Drive Tumor Progression by UNIACKE, James, KISHAN PERERA, J, LACHANCE, Gabriel, FRANCISCO, Camille B, LEE, Stephen

“…Human tumors display considerable diversity in their genetic makeup but share common physiologic attributes such as a hypoxic microenvironment that contribute…”
Get full text

Narcotic Use and Total Knee Arthroplasty by Cancienne, Jourdan M., Patel, Kishan J., Browne, James A., Werner, Brian C.

“…Although the United States is in the midst of a narcotic epidemic, risk factors for use and the impact of perioperative narcotic use on total knee arthroplasty…”
Get full text

Risk Factors for Repeat Debridement, Spacer Retention, Amputation, Arthrodesis, and Mortality After Removal of an Infected Total Knee Arthroplasty With Spacer Placement by Cancienne, Jourdan M., Granadillo, Victor A., Patel, Kishan J., Werner, Brian C., Browne, James A.

“…Chronic periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) is most commonly addressed with a 2-stage exchange procedure. The purpose of…”
Get full text

Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590) by Bhatia, Aarti K., Lee, Ju‐Whei, Pinto, Harlan A., Jacobs, Charlotte D., Limburg, Paul J., Rubin, Philip, Arusell, Robert M., Dunphy, Eamonn P., Khandekar, Janardan D., Reiner, Seth A., Baez‐Diaz, Luis, Celano, Paul, Li, Shuli, Li, Yi, Burtness, Barbara A., Adams, George L., Pandya, Kishan J.

“…BACKGROUND 13‐Cis retinoic acid (13‐CRA) is a synthetic vitamin A derivative. High‐dose 13‐CRA in patients with squamous cell cancers of the head and neck…”
Get full text

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer by Kim, Eric S, Baran, Andrea M, Mondo, Esther L, Rodgers, Thomas D, Nielsen, Gradon C, Dougherty, David W, Pandya, Kishan J, Rich, David Q, Wijngaarden, Edwin van

“…Carboplatin is widely used to treat lung cancer in the United States as an alternative to cisplatin. Several studies have demonstrated that cisplatin-based…”
Get full text

Dysphagia, Hyperglycemia, and Presyncope by Padalia, Kishan J., Padalia, Arjun J., Parikh, Milind G.

“…There have been over 80 documented cases of swallow syncope—a rare form of reflex or neurally mediated syncope—with most cases associated with an underlying…”
Get full text

A Rare Case of Ruptured Appendicitis Secondary to Metastatic Ovarian Cancer by Raman, Alex G, Huynh, James, Patel, Kishan J, Kong, Lynn R, Barrows, Brad D, Hubeny, Charles

“…BACKGROUND Patients with advanced stage ovarian cancer typically have vague non-specific abdominal symptoms related to pelvic tumor, metastasis, and ascites…”
Get full text

Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015 by Pithadia, Kishan J, Advani, Pragati G, Citrin, Deborah E, Bekelman, Justin E, Withrow, Diana R, Berrington de Gonzalez, Amy, Morton, Lindsay M, Schonfeld, Sara J

“…Compared with 3-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT) can spare nearby tissue but may result in increased scatter…”
Get more information

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma by BRIZEL, David M, MURPHY, Barbara A, ROSENTHAL, David I, PANDYA, Kishan J, GLÜCK, Stefan, BRIZEL, Herbert E, MEREDITH, Ruby F, BERGER, Dietmar, CHEN, Mon-Gy, MENDENHALL, William

“…Acute mucositis is a dose-limiting toxicity of concurrent chemoradiotherapy regimens for locally advanced head and neck cancer. Palifermin (a recombinant human…”
Get full text

A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500) by Pandya, Kishan J, Dahlberg, Suzanne, Hidalgo, Manuel, Cohen, Roger B, Lee, Martin W, Schiller, Joan H, Johnson, David H

“…To study the progression-free survival (PFS) and toxicity with 25- or 250-mg doses of temsirolimus (CCI-779) after induction chemotherapy in patients with…”
Get more information

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial by Pandya, Kishan J, Morrow, Gary R, Roscoe, Joseph A, Zhao, Hongwei, Hickok, Jane T, Pajon, Eduardo, Sweeney, Thomas J, Banerjee, Tarit K, Flynn, Patrick J

“…Most women receiving systemic therapy for breast cancer experience hot flashes. We undertook a randomised, double-blind, placebo-controlled,…”
Get full text

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533 by Wozniak, Antoinette J, Moon, James, Thomas, Charles R, Kelly, Karen, Mack, Philip C, Gaspar, Laurie E, Raben, David, Fitzgerald, Thomas J, Pandya, Kishan J, Gandara, David R

“…Micro-Abstract The incorporation of bevacizumab with concurrent chemoradiotherapy (CRT) in the treatment of locally advanced non–small-cell lung cancer (NSCLC)…”
Get full text

Assessing Persistent Cancer Pain: A Comparison of Current Pain Ratings and Pain Recalled from the Past Week by Shi, Qiuling, PhD, Wang, Xin Shelley, MD, MPH, Mendoza, Tito R., PhD, Pandya, Kishan J., MD, Cleeland, Charles S., PhD

“…Abstract Recent guidelines developed by the U.S. Food and Drug Administration for the use of patient-reported outcomes discuss the rating of pain and other…”
Get full text

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer by Lin, Hongmei, Chen, Yuhchyau, Shi, Anhui, Pandya, Kishan J, Yu, Rong, Yuan, Yannan, Li, Jiancheng, Li, Hang, Wang, Yingjie, Xia, Tingyi, Feng, Linchun, Ma, Huimin, Geng, Jianhao, Zhu, Guangying

“…Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC) but is associated with poor chest…”
Get full text

Successful Bypass Surgery in a Healthy 24-Year-Old Male with Peripheral Artery Disease by Padalia, Kishan J, Muehlberger, Michael J

“…Approximately 40% of peripheral artery disease cases occur in individuals less than 50 years old. Diagnosis is often delayed due to fewer risk factors,…”
Get full text

Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer by Pandya, Kishan J, Gajra, Ajeet, Warsi, Ghulam M, Argonza-Aviles, Eliza, Ericson, Solveig G, Wozniak, Antoinette J

“…Abstract This study was designed to evaluate the efficacy and safety of combined zoledronic acid and docetaxel/carboplatin in patients with non-small cell lung…”
Get full text

Aqueous combustion synthesis and characterization of zirconia–alumina nanocomposites by Kishan, J., Mangam, Venu, Reddy, B.S.B., Das, Siddhartha, Das, Karabi

“…The zirconia–alumina nanocomposite powders with 3–48 mol% of alumina are prepared by aqueous combustion synthesis technique using stoichiometric amounts of…”
Get full text

Preclinical and Pilot Clinical Studies of Docetaxel Chemoradiation for Stage III Non–Small-Cell Lung Cancer by Chen, Yuhchyau, M.D., Ph.D, Pandya, Kishan J., M.D, Hyrien, Ollivier, Ph.D, Keng, Peter C., Ph.D, Smudzin, Therese, B.S, Anderson, Joy, M.D, Qazi, Raman, M.D, Smith, Brian, M.D, Watson, Thomas J., M.D, Feins, Richard H., M.D, Johnstone, David W., M.D

“…Purpose Local and distant failure rates remain high despite aggressive chemoradiation (CRT) treatment for Stage III non–small-cell lung cancer. We conducted…”
Get full text

Advances in personalized therapy for lung cancer by Kim, Eric S, Pandya, Kishan J

“…Personalized medicine based on tumor characteristics is transforming the management of lung cancer. This review provides an overview of clinically approved…”
Get more information